Effect of Chinese herbal medicine on food allergy
Effect of Chinese herbal medicine on food allergy
批准号:
7880954
负责人:
Xiu-Min Li
金额:
$71.81万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-01 至 2012-09-30
关键词:
AccountingAcuteAdultAffectAgeAllergy to peanutsAnaphylaxisAnimal ModelAreaBiological AssayBotanicalsButanolsCD8B1 geneCellsCharacteristicsChemicalsChildChinese HerbsChinese Traditional MedicineChronicClinicalClinical ResearchClinical TrialsCohort StudiesComplexDevelopmentDoseDouble-Blind MethodDrug KineticsEnrollmentEthanolExhibitsFishesFoodFood HypersensitivityFosteringFractionationGoalsGrantHealthHealthy People 2010Herbal MedicineHigh Pressure Liquid ChromatographyHumanHypersensitivityIgEImmunosuppressionImmunotherapeutic agentIn VitroInterleukin-13Interleukin-5InterventionInvestigational DrugsKnowledgeLeadMass Spectrum AnalysisMethodsModelingMonitorMusNatureNew Drug ApprovalsNut HypersensitivityNutsOralOutcomePatientsPeanuts - dietaryPeripheral Blood Mononuclear CellPersonsPharmaceutical PreparationsPhasePhase I Clinical TrialsPhenotypePhytotherapyPlacebo ControlProductionProductivityQuality of lifeResearchResearch Ethics CommitteesRiskSafetyShellfishT-LymphocyteTabletsTechnologyTreesUnited Statesage groupaqueousbasecohortcytokinedrug developmentimprovedin vivomedical schoolsopen labelphase 1 studyprogramspublic health relevancerandomized placebo controlled trialsafety study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Food allergy is a growing and serious health concern in the United States. There is no definitive treatment for PN or other food allergies. In our initial R01 grant project, we developed Food Allergy Herbal Formula-2 (FAHF-2) and showed that it completely blocked PN-induced anaphylaxis in a murine model and had a high safety profile. Protection persisted up to 6 months post therapy, and was associated with immunomodulatory effect, but not overall immune suppression. These results demonstrate that FAHF-2 is an optimal candidate for developing a botanical drug for treating food allergies. We began the FAHF-2 phase I clinical study have obtained FDA IND and IRB approvals. In this renewal application, we propose to investigate the persistent effect of FAHF-2 on food allergy, and investigate the immunotherapeutic mechanisms, and chemical and pharmacological characteristics of FAHF-2. We will pursue two specific Aims to continue this study. Aim #1. Investigate the safety and efficacy of FAHF-2 in food allergy patients: In this aim we will investigate the safety and efficacy of FAHF-2 on PN, TN, fish, and shellfish allergies, the most severe and chronic food allergies, in a12-45 year old age group. We are conducting an acute phase I study, followed by a long-term, open-label extension study of 6 months duration. After completing these safety studies, we will conduct a phase II double-blind, randomized, placebo-controlled trial. We will use standard methods such as double- blind, placebo-controlled oral food challenges to evaluate the clinical outcomes including long-term efficacy. We will also study the immunomodulatory mechanism focusing on IFN-3 production of CD8+ T cells. Aim #2. Refine FAHF-2 product and Investigate chemical and pharmacological characteristics of B-FAHF-2: Our current IND, FAHF-2, is a partially refined, but still curded herbal product. We propose to further refine this product, using butanol purification because butanol fractionation (B-FAHF-2) significantly reduced the effective daily dose and remained efficacy in our animal model of PNA. B-FAHF-2 might be the preferred starting point for isolation of active components. We will use a combination of chemical analysis (HPLC, mass spectrometry and NMR) and bioassays to isolate and identify active components in B-FAHF-2, and then begin preliminary pharmacokinetic studies in mice. This is the first clinical investigation of a botanical drug for multiple persistent food allergies. Accomplishing this study will be of fundamental importance to validate the possible clinical usefulness of this Chinese herbal medicine in PNA and other food allergies, and to understand the mechanisms of action. We will also be able to further refine FAHF-2 product to improve our clinical study, and identify active compounds for the purpose of understanding pharmacological characteristics of this complex botanical product Ultimately, this study may lead to a safe and effective herbal therapy for food allergy. PUBLIC HEALTH RELEVANCE: Food allergy is a growing and serious health concern in the US and is now the leading cause of anaphylactic reactions; at present, there is no definitive treatment for peanut or other food allergies. During our initial R01 grant project, we generated Food Allergy Herbal Formula (FAHF-2) derived from a classical traditional Chinese medicine formula, and demonstrated its efficacy, safety and persistent effect in a murine model of peanut allergy; we propose in this renewal to investigate the safety, efficacy and systemic immunotherapeutic mechanisms of FAHF-2 on peanut, treenut, fish and shellfish allergies of patients ages 12-45, for which we have received IND approval under the botanical drug program (IND77,468). This will foster the development of scientific knowledge of TCM treatment for improving the health, productivity, independence, and quality of life of persons with food allergies and is thus congruent with the goals of Healthy People 2010 and may lead to a safe and effective herbal therapy for food allergy.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/msj.20294
发表时间:
2011-09
期刊:
MOUNT SINAI JOURNAL OF MEDICINE
影响因子:
--
作者:
[Li, Xiu-Min]
通讯作者:
Li, Xiu-Min
DOI:
10.1016/j.iac.2017.09.012
发表时间:
2018
期刊:
Immunology and allergy clinics of North America
影响因子:
2.6
作者:
[Li,Xiu-Min]
通讯作者:
Li,Xiu-Min
DOI:
10.1016/j.anai.2010.05.005
发表时间:
2010-07
期刊:
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
影响因子:
5.9
作者:
[Wang, Julie, Patil, Sangita P., Yang, Nan, Ko, Jimmy, Lee, Joohee, Noone, Sally, Sampson, Hugh A., Li, Xiu-Min]
通讯作者:
Li, Xiu-Min
DOI:
10.1111/cea.12936
发表时间:
2017-08
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
[Srivastava KD, Song Y, Yang N, Liu C, Goldberg IE, Nowak-Węgrzyn A, Sampson HA, Li XM]
通讯作者:
Li XM
DOI:
10.1016/j.jaci.2015.04.029
发表时间:
2015-10
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Wang J, Jones SM, Pongracic JA, Song Y, Yang N, Sicherer SH, Makhija MM, Robison RG, Moshier E, Godbold J, Sampson HA, Li XM]
通讯作者:
Li XM
共 15 条
IgE-suppressing small molecule compound Xanthopurpurin analog for multiple food allergies
-
批准号:10761370
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2023
-
负责人:Xiu-Min Li
-
依托单位:
IgE Suppressing Berberine Nanomedicine for Treatment of Food Allergies
-
批准号:10698900
-
项目类别:
-
资助金额:$92.02万
-
财政年份:2023
-
负责人:Xiu-Min Li
-
依托单位:
IgE Suppressing Berberine Nanomedicine for Treatment of Peanut and Tree nut Allergies
-
批准号:10649110
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2023
-
负责人:Xiu-Min Li
-
依托单位:
CLINICAL EFFECT OF A CHINESE HERBAL THERAPY IN HUMAN ASTHMA-PHASE II, PROJECT 2
-
批准号:7953734
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2009
-
负责人:Xiu-Min Li
-
依托单位:
Therapy (CHT) for Asthma
-
批准号:7475496
-
项目类别:
-
资助金额:$79.45万
-
财政年份:2007
-
负责人:Xiu-Min Li
-
依托单位:
Administrative Core
-
批准号:7051242
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Project 1 - Effects and Mechanisms of CHT in an Asthma Model
-
批准号:7051237
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Project 3 - Chemical and Biological Characterization of Botanicals
-
批准号:7051240
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Center for Chinese Herbal Therapy (CHT) for Asthma
-
批准号:7288396
-
项目类别:
-
资助金额:$110.27万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Center for Chinese Herbal Therapy (CHT) for Asthma
-
批准号:7687529
-
项目类别:
-
资助金额:$108.07万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Center for Chinese Herbal Therapy (CHT) for Asthma
-
批准号:7022017
-
项目类别:
-
资助金额:$114.43万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Center for Chinese Herbal Therapy (CHT) for Asthma
-
批准号:7126542
-
项目类别:
-
资助金额:$110.27万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Center for Chinese Herbal Therapy (CHT) for Asthma
-
批准号:7785525
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Project 2 - Clinical Trial of CHT in Asthma Patients
-
批准号:7051238
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2005
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:7121749
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:7175490
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:7655880
-
项目类别:
-
资助金额:$69.52万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:6723353
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:6839984
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
Effect of Chinese herbal medicine on food allergy
-
批准号:7002165
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2004
-
负责人:Xiu-Min Li
-
依托单位:
海外基金